CORGENIX MEDICAL CORP/CO 4

4 · CORGENIX MEDICAL CORP/CO · Filed Mar 11, 2015

Form 4

Period: 2015-03-10

Senior Vice President/CFO

Transactions

Disposition to Issuer
''Right to buy'' common stock options
2015-03-10−150,000→ 0 total
Exercise: $0.09From: 2011-08-29Exp: 2018-08-29→ Common Stock (150,000 underlying)
Disposition to Issuer
''Right to buy'' common stock options
2015-03-10−100,000→ 0 total
Exercise: $0.10From: 2010-08-12Exp: 2017-08-12→ Common Stock (100,000 underlying)
Disposition to Issuer
Common Stock
2015-03-10$0.27/sh−366,545$98,967→ 0 total
Disposition to Issuer
''Right to buy'' common stock options
2015-03-10−200,000→ 0 total
Exercise: $0.21From: 2013-08-27Exp: 2020-08-27→ Common Stock (200,000 underlying)

Footnotes (4)

[F1]Disposed of in exchange for a cash payment of $0.27 per share pursuant to that certain Agreement and Plan of Merger, dated as of August 27, 2014, by and among Corgenix Medical Corp ("Corgenix"), Centennial Medical Holdings, Inc. ("Centennial") and Centennial Integrated, Inc., a wholly owned subsidiary of Centennial, pursuant to which Corgenix has been acquired by Centennial (the "Merger").
[F2]This option, which has vested in full, was cancelled in the Merger in exchange for a cash payment of $11,000, representing (a) the number of shares underlying the option, multiplied by (b) the excess of $0.27 over the exercise price per share of the option (the "Option Merger Consideration").
[F3]This option, which has vested in full, was cancelled in the Merger in exchange for a cash payment of $27,750, representing the Option Merger Consideration.
[F4]This option, which has vested in full, was cancelled in the Merger in exchange for a cash payment of $17,500, representing the Option Merger Consideration.

Documents

1 file